Stuart Essig Email and Phone Number
Stuart Essig work email
- Valid
- Valid
- Valid
Stuart Essig personal email
- Valid
Stuart Essig phone numbers
Stuart Essig is Executive Chairman of Integra LifeSciences Holdings Corporation (NASDAQ: IART). He served as the company’s chief executive officer from 1997 to 2012, building Integra into a global surgical products leader. During Stuart’s 26-year tenure with the company, Integra has grown revenues from $15 million to over $1.6 billion and its market capitalization from approximately $100 million to an enterprise valuation of more than $6.0 billion. Stuart serves as managing partner of Prettybrook Partners, LLC. He is a director of IDEXX Laboratories, Inc. (NASDAQ:IDXX), Mission Bio and Availity, LLC. Previously, Stuart served on the boards of Orthofix Medical, Inc. (NASDAQ:OFIX), Seaspine Corporation (NASDAQ:SPNE), St. Jude Medical (NYSE:STJ), Zimmer Biomet Holdings, Inc. (NYSE: ZBH), Owens & Minor, Inc. (NYSE: OMI) and Vital Signs, Inc. (NASDAQ:VITL). He previously was lead director and formerly chairman of the Board of Directors of private equity-backed Breg, Inc. Prior to Integra, Stuart was a managing director in mergers and acquisitions for the Goldman Sachs Group, Inc., specializing in the medical device, pharmaceutical and biotechnology sectors. After earning his undergraduate degree from Princeton University, Stuart earned a master’s in business administration and a Ph.D. in financial economics from the University of Chicago.Stuart is a global executive who has built and managed profitable sales, marketing and general business operations. He developed diverse sets of leaders across multiple corporations. He executed on an effective succession planning process whereby the company he led for fifteen years effectively recruited his successor.Stuart has chaired Audit, Compensation, Finance and Nominating and Governance Committees and served on the boards of several Fortune 500, NASDAQ and NYSE listed companies ranging in size from several hundred million dollars to more than $55 billion in market capitalization. He has served on the Executive committee, Nominating and Governance committee and as Treasurer of ADVAMED, the Advanced Medical Technology Association.
-
Managing PartnerPrettybrook Partners Llc Oct 2012 - PresentAustin, Tx, Texas, UsPrettybrook Partners is a private investment firm with the primary purpose of preserving capital and generating compounding cash returns. The firm makes long-term investments in businesses with superior growth prospects and high quality management teams. -
Chairman Of The Board Of DirectorsIntegra Lifesciences Jan 2012 - PresentPrinceton, New Jersey, UsHas served as Executive Chairman since February 2024. Previously served as Non-Executive Chairman from June 2012 until February 2024 and served as Executive Chairman from January 2012 until June 2012. Focused on strategy, acquisitions and governance. Served as Chief Executive Officer from December 1997 until January 2012, and President from December 1997 until November 2010. Served as a director since joining Integra in December 1997.Integra LifeSciences, a world leader in medical devices, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in neurosurgery, and reconstructive and general surgery. -
Chief Executive OfficerIntegra Lifesciences 1997 - Jan 2012Princeton, New Jersey, UsServed as Chief Executive Officer from December 1997 until January 2012, and President from December 1997 until November 2010. In addition, served as a director since December 1997. Integra LifeSciences, a world leader in medical devices, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in neurosurgery, spine surgery, orthopedic surgery and reconstructive and general surgery.Responsible for global strategy, marketing and P&L for $800 million revenue medical device company. Developed strategies to enter neurosurgery, extremities, surgical instruments and spine markets. Grew revenues from $15 million to over $800 million. Grew headcount from 100 employees to over 3,500 employees. Grew EBITDA from a $10 million loss to $168 million. Grew equity market capitalization from $60 million to $1.2 billion. Grew levered market capitalization from $35 million to $1.6 billion.Executed $125 million equity transaction, and four convertible bond financings raising $700 million. Executed several bank financing transactions culminating in $600 million term loan plus revolver at LIBOR plus 125. Consummated approximately 40 acquisitions ranging from several million to over $100 million in value. Acquired both private and public companies. Took company from no investor research coverage to having almost twenty analysts following the company.Recognized by Forbes magazine as one of "Americas 100 Best Small Companies" in 2004, 2005, 2006, 2008, 2009 and 2010. In 2011, Integra was listed as one of "New Jersey's 50 Fastest Growing Companies" by NJBIZ. -
Chairman Of The Board Of DirectorsMission Bio Feb 2022 - PresentSouth San Francisco, California, UsMember, Audit CommitteeMember, Compensation CommitteeMission Bio is a life sciences company that accelerates discoveries and cures for a wide range of diseases by equipping researchers with the tools they need to better measure and predict our resistance and response to new therapies. Mission Bio's multi-omics approach improves time-to-market for new therapeutics, including innovative cell and gene therapies that provide new pathways to health. -
DirectorIdexx Jul 2017 - PresentWestbrook, Maine, UsChairman, Finance CommitteeMember, Governance and Corporate Responsibility CommitteeIDEXX Laboratories, Inc. is a member of the S&P 500® Index and is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency, and build more economically successful practices. IDEXX is also a worldwide leader in providing livestock and poultry diagnostic tests and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX employs more than 7,000 people and offers products to customers in over 175 countries. -
Independent ManagerAvaility Feb 2019 - PresentJacksonville, Fl, UsChairman, Audit CommitteeMember, Finance CommitteeAvaility is the place where healthcare finds the answers needed to shift focus back to patient care. By solving the communication challenges between healthcare stakeholders, Availity creates a richer, more transparent exchange of information among health plans, providers, and technology partners. As the nation’s largest health information network, Availity facilitates over 4 billion clinical, administrative, and financial transactions annually. The company’s suite of dynamic products, built on a powerful, intelligent platform, enables real-time collaboration for success in a competitive, value-based care environment. -
Board ObserverDynatronics May 2015 - PresentSalt Lake City, Utah, UsDynatronics Corporation is a manufacturer and marketer of rehabilitation and physical therapy products. Prettybrook partners led a $4 million private investment in this public company. -
Senior Advisory BoardTowerbrook Capital Partners 2010 - PresentLondonTowerBrook is an investment management firm with a differentiated strategy and a track record of creating value for investors. The firm is based in Europe and the USA and focuses on making investments in European and North American companies. TowerBrook pursues control-oriented investments in large and middle market companies, partnering with highly capable management teams and seeking situations characterised by complexity. -
Management Advisory BoardTowerbrook Capital Partners 2005 - 2010LondonTowerBrook is an investment management firm with a differentiated strategy and a track record of creating value for investors. The firm is based in Europe and the USA and focuses on making investments in European and North American companies. TowerBrook pursues control-oriented investments in large and middle market companies, partnering with highly capable management teams and seeking situations characterised by complexity. -
Venture PartnerWellington Partners Mar 2013 - PresentMunich, Bavaria, DeWellington Partners is among the most successful pan-European Venture Capital firms. With more than € 800 million under management and offices in Munich, London and Zurich, Wellington Partners invests in start-up companies throughout Europe that have the potential to become global leaders in the areas of digital media, resource efficiency and life sciences. Since 1998, Wellington Partners has invested in more than 100 companies, including publicly listed firms like Actelion, Evolva, Wavelight (acquired by Alcon) and Xing as well as privately held companies like AyoxxA, Grandis (acquired by Novartis), immatics, implanet, invendo medical, mtm laboratories (acquired by Roche), Oxagen, Oxford Immunotec, Quanta, Sapiens, Sensimed, Supersonic Imagine, Symetis and Spotify. For further information, please visit www.wellington-partners.com. -
DirectorOrthofix Jan 2023 - Jun 2024Lewisville, Tx, UsChairman, Nominating, Governance & Sustainability CommitteeMember, Audit CommitteeOrthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company’s mission is to deliver innovative, quality-driven solutions while partnering with health care professionals to improve patient mobility. Headquartered in Lewisville, Texas, Orthofix’s spine and orthopedics products are distributed in more than 60 countries via the Company's sales representatives and distributors. -
Lead Director, Formerly Chairman Of The Board Of DirectorsBreg Jul 2012 - May 2024Carlsbad, California, UsChairman, Audit CommitteeMember, Compensation CommitteeBreg, Inc. is a premier provider of sports medicine products and services. Water Street Healthcare Partners, a strategic private equity firm focused exclusively on the health care industry, invested in Breg in June, 2012 with plans to build it into a market leader specializing in nonsurgical orthopedic products. Play a leadership role in working with Breg management team on developing strategies for growing the company. -
DirectorSeaspine Inc May 2015 - Jan 2023Carlsbad, Ca, UsLead Independent DirectorChairman, Governance and Nominating CommitteeWith more than 18 years of innovation in the spine and orthobiologics markets, SeaSpine is dedicated to improving the lives of spine patients, collaborating with surgeons and developing the most advanced and effective spinal surgery technologies. Played a leading role in effectuating the spin-off of this company to the shareholders of Integra LifeSciences and it's establishment as a publicly traded company. Seaspine merged with Orthofix in 2023. -
Executive AdvisorWater Street Healthcare Partners Llc Jul 2015 - Jan 2021Chicago, Illinois, UsWater Street focuses exclusively on growing market leaders in four segments of healthcare: medical and diagnostic products, specialty distribution, outsourced healthcare services, and specialty pharmaceutical products and services. Water Street has nearly $2 billion to invest in its companies. We actively seek companies that we believe are well positioned for transformational growth. We work with management to accelerate growth by expanding product breadth, service capabilities and geographic reach. We pride ourselves on being skilled enablers— we offer the full benefit of our experience and industry relationships in support of management. Water Street has a history of successful partnerships with both large, global companies interested in maximizing the value of their non-core healthcare divisions and middle-market companies looking for a partner to accelerate growth. -
DirectorOwens & Minor Oct 2013 - Aug 2019Mechanicsville, Va, UsServed on Nominating and Governance Committee, Compensation Committee and Audit CommitteeOwens & Minor, Inc., a FORTUNE 500 company headquartered in Richmond, Virginia, is a leading national provider of distribution and logistics services to the healthcare industry and a leading European provider of logistics services to pharmaceutical, life-science, and medical-device manufacturers. With a diverse product and service offering and facilities throughout the United States and Europe, the company serves hospitals, integrated healthcare systems, alternate site locations, group purchasing organizations, healthcare manufacturers, and the federal government. Owens & Minor also provides technology and consulting programs that improve inventory management and streamline logistics across the entire medical supply chain. -
Executive In ResidenceCardinal Partners Sep 2012 - May 2018Cardinal Partners has been one of the leading venture capital partnerships focused exclusively on healthcare investing. Cardinal specializes in early stage financing rounds, usually as the lead investor in the initial financing round of a growth company.
-
Founding Investor MemberTigerlabs 2012 - 2018Princeton, New Jersey, UsTigerlabs is an entrepreneurship campus founded by serial entrepreneurs & venture capitalists with the goal of organizing the fast growing but disjointed startup ecosystem of Princeton, NJ.Located in downtown Princeton, Tigerlabs provides a flexible co-working venue for emerging startup companies and offers startup education workshops and events open to the community. In addition, through Tigerlabs Health and Tigerlabs University, we provide startups with seed capital, mentorship from key industry executives, a variety of perks, and a shared collaborative hackerspace for passionate students and individuals to pursue careers in technology entrepreneurship. -
DirectorSt. Jude Medical 1999 - Jan 2017St. Paul, Minnesota, UsServed as Chairman, Compensation Committee, Chairman, Governance and Nominating Committee and Chairman, Audit CommitteeSt. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. St. Jude Medical is headquartered in St. Paul, Minnesota and has four major focus areas that include: cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation. -
DirectorZimmer Mar 2005 - Aug 2008Warsaw, Indiana, UsServed as Chairman, Compensation and Management Development Committee, Member, Audit Committee and Member Corporate Governance Committee. Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. -
DirectorVital Signs 1998 - 2002Vital Signs is a global provider of medical products applicable to a wide range of care areas such as anesthesia, respiratory, sleep therapy and emergency medicine. Vital Signs has a broad product offering of innovative single-patient use products which offer significant cost advantages and improved patient care features, including reducing the likelihood of transmitting infections from one patient to another. Vital Signs became part of GE Healthcare’s Clinical Systems business, a world-class provider of advanced technologies for patient monitoring, anesthesia delivery and acute respiratory care in 2008.
-
Managing DirectorGoldman Sachs 1987 - 1997New York, New York, UsSpecialized in Mergers and Acquisitions, Financing and Investing. Managing Director, Healthcare. One of three Managing Directors leading a team of investment bankers focused on the medical device, pharmaceutical and biotechnology sectors. Vice President, Mergers and Acquisitions. Key Significant M&A Transactions included: Amsco/Steris; Bristol-Myers/Squibb; Daig/St. Jude; Dennison/Avery; Dracket/S.C. Johnson; Elan/Athena; Galen/Columbia; Heart Technology/Boston Scientific; Incentive/Gambro; Nellcor /Puritan Bennett; SciMed/Boston Scientific; Square-D/Schneider; Upjohn/Pharmacia. Key clients included 3M, Amsco, Bain, Biogen, Boston Scientific, Bristol-Myers Squibb, Clorox, Elan, Elekta, Kohlberg & Co., Mallinckrodt, Medtronic, Nellcor, Pharmacia, SciMed, St. Jude, Upjohn, Ventritex. -
DirectorNeuromedical Systems, Inc. 1993 - 1996Neuromedical Systems, Inc. was a healthcare technology company focused on diagnostic screening applications to aid in the early detection of certain cancers. Neuromedical's first product, the PAPNET(R) Testing System, increases the accuracy of cervical screening by displaying potentially abnormal cells for review and analysis by a cytology professional. Neuromedical Systems was acquired by Tripath Imaging which subsequently became part of Becton Dickinson.
-
Adjunct Professor, Weekend Mba ProgramUniversity Of Chicago Booth School Of Business 1994 - 1995Chicago, Illinois, UsCo-taught an introductory course in accounting and finance in the weekend MBA program covering topics in financial analysis and corporate finance with Professor Mark Zmijewski. -
First Boston Summer Associate, Mergers And AcquisitionsCredit Suisse 1987 - 1987Zurich, ChParticipated in a broad range of investment banking activities including mergers and acquisitions, issuance of debt and equity, capital market, and international business development. -
Junior FellowThe Chinese University Of Hong Kong 1983 - 1984Shatin, Nt, HkEconomics Department. Taught courses on macro-and microeconomics and contemporary economic issues.
Stuart Essig Education Details
-
The University Of Chicago Booth School Of BusinessFinancial Economics -
The University Of Chicago Booth School Of BusinessFinancial Economics -
Princeton UniversityWoodrow Wilson School Of Public And International Affairs
Frequently Asked Questions about Stuart Essig
What company does Stuart Essig work for?
Stuart Essig works for Prettybrook Partners Llc
What is Stuart Essig's role at the current company?
Stuart Essig's current role is Managing Partner at Prettybrook Partners.
What is Stuart Essig's email address?
Stuart Essig's email address is st****@****ail.com
What is Stuart Essig's direct phone number?
Stuart Essig's direct phone number is +160974*****
What schools did Stuart Essig attend?
Stuart Essig attended The University Of Chicago Booth School Of Business, The University Of Chicago Booth School Of Business, Princeton University.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial